HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Waldo Ortuzar Feliu Selected Research

balstilimab

11/2021Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.
9/2021RaPiDS (GOG-3028): randomized Phase II study of balstilimab alone or in combination with zalifrelimab in cervical cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Waldo Ortuzar Feliu Research Topics

Disease

2Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 09/2021
1Neoplasms (Cancer)
11/2021

Drug/Important Bio-Agent (IBA)

2balstilimabIBA
11/2021 - 09/2021
2PlatinumIBA
11/2021 - 09/2021

Therapy/Procedure

1Drug Therapy (Chemotherapy)
09/2021